News
-
-
-
COMMUNIQUÉ DE PRESSE
BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
-
COMMUNIQUÉ DE PRESSE
BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
-
-
-
COMMUNIQUÉ DE PRESSE
Bionxt Solutions Announces Convertible Debenture and Interest Settlement
-
-
-